nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoteridol—Vomiting—Temsirolimus—kidney cancer	0.00212	0.00212	CcSEcCtD
Gadoteridol—Shock—Sorafenib—kidney cancer	0.00212	0.00212	CcSEcCtD
Gadoteridol—Dry mouth—Sunitinib—kidney cancer	0.00212	0.00212	CcSEcCtD
Gadoteridol—Rash—Temsirolimus—kidney cancer	0.00211	0.00211	CcSEcCtD
Gadoteridol—Dermatitis—Temsirolimus—kidney cancer	0.0021	0.0021	CcSEcCtD
Gadoteridol—Headache—Temsirolimus—kidney cancer	0.00209	0.00209	CcSEcCtD
Gadoteridol—Dizziness—Pazopanib—kidney cancer	0.00208	0.00208	CcSEcCtD
Gadoteridol—Oedema—Sunitinib—kidney cancer	0.00208	0.00208	CcSEcCtD
Gadoteridol—Feeling abnormal—Vinblastine—kidney cancer	0.00206	0.00206	CcSEcCtD
Gadoteridol—Injection site reaction—Doxorubicin—kidney cancer	0.00205	0.00205	CcSEcCtD
Gadoteridol—Pain—Erlotinib—kidney cancer	0.00205	0.00205	CcSEcCtD
Gadoteridol—Feeling abnormal—Everolimus—kidney cancer	0.00205	0.00205	CcSEcCtD
Gadoteridol—Shock—Sunitinib—kidney cancer	0.00204	0.00204	CcSEcCtD
Gadoteridol—Erythema—Gemcitabine—kidney cancer	0.00204	0.00204	CcSEcCtD
Gadoteridol—Discomfort—Dactinomycin—kidney cancer	0.00202	0.00202	CcSEcCtD
Gadoteridol—Dysphagia—Capecitabine—kidney cancer	0.00201	0.00201	CcSEcCtD
Gadoteridol—Salivary hypersecretion—Doxorubicin—kidney cancer	0.00201	0.00201	CcSEcCtD
Gadoteridol—Vomiting—Pazopanib—kidney cancer	0.002	0.002	CcSEcCtD
Gadoteridol—Bradycardia—Paclitaxel—kidney cancer	0.002	0.002	CcSEcCtD
Gadoteridol—Rash—Pazopanib—kidney cancer	0.00198	0.00198	CcSEcCtD
Gadoteridol—Nausea—Temsirolimus—kidney cancer	0.00198	0.00198	CcSEcCtD
Gadoteridol—Dermatitis—Pazopanib—kidney cancer	0.00198	0.00198	CcSEcCtD
Gadoteridol—Abdominal pain—Vinblastine—kidney cancer	0.00197	0.00197	CcSEcCtD
Gadoteridol—Headache—Pazopanib—kidney cancer	0.00197	0.00197	CcSEcCtD
Gadoteridol—Rhinitis—Paclitaxel—kidney cancer	0.00197	0.00197	CcSEcCtD
Gadoteridol—Oedema—Dactinomycin—kidney cancer	0.00196	0.00196	CcSEcCtD
Gadoteridol—Abdominal pain—Everolimus—kidney cancer	0.00196	0.00196	CcSEcCtD
Gadoteridol—Body temperature increased—Everolimus—kidney cancer	0.00196	0.00196	CcSEcCtD
Gadoteridol—Fluid retention—Doxorubicin—kidney cancer	0.00196	0.00196	CcSEcCtD
Gadoteridol—Dyspnoea—Sorafenib—kidney cancer	0.00192	0.00192	CcSEcCtD
Gadoteridol—Abdominal pain—Erlotinib—kidney cancer	0.00189	0.00189	CcSEcCtD
Gadoteridol—Body temperature increased—Erlotinib—kidney cancer	0.00189	0.00189	CcSEcCtD
Gadoteridol—Ill-defined disorder—Gemcitabine—kidney cancer	0.00189	0.00189	CcSEcCtD
Gadoteridol—Rash maculo-papular—Doxorubicin—kidney cancer	0.00188	0.00188	CcSEcCtD
Gadoteridol—Nausea—Pazopanib—kidney cancer	0.00187	0.00187	CcSEcCtD
Gadoteridol—Paraesthesia—Sunitinib—kidney cancer	0.00186	0.00186	CcSEcCtD
Gadoteridol—Convulsion—Vincristine—kidney cancer	0.00186	0.00186	CcSEcCtD
Gadoteridol—Hypertension—Vincristine—kidney cancer	0.00186	0.00186	CcSEcCtD
Gadoteridol—Dyspnoea—Sunitinib—kidney cancer	0.00185	0.00185	CcSEcCtD
Gadoteridol—Pain—Sorafenib—kidney cancer	0.00184	0.00184	CcSEcCtD
Gadoteridol—Malaise—Gemcitabine—kidney cancer	0.00184	0.00184	CcSEcCtD
Gadoteridol—Hypersensitivity—Vinblastine—kidney cancer	0.00184	0.00184	CcSEcCtD
Gadoteridol—Hypersensitivity—Everolimus—kidney cancer	0.00183	0.00183	CcSEcCtD
Gadoteridol—Tinnitus—Paclitaxel—kidney cancer	0.00183	0.00183	CcSEcCtD
Gadoteridol—Flushing—Paclitaxel—kidney cancer	0.00182	0.00182	CcSEcCtD
Gadoteridol—Cough—Gemcitabine—kidney cancer	0.00178	0.00178	CcSEcCtD
Gadoteridol—Pain—Sunitinib—kidney cancer	0.00177	0.00177	CcSEcCtD
Gadoteridol—Hypertension—Gemcitabine—kidney cancer	0.00176	0.00176	CcSEcCtD
Gadoteridol—Pruritus—Everolimus—kidney cancer	0.00176	0.00176	CcSEcCtD
Gadoteridol—Oedema—Vincristine—kidney cancer	0.00176	0.00176	CcSEcCtD
Gadoteridol—Anaphylactic shock—Vincristine—kidney cancer	0.00176	0.00176	CcSEcCtD
Gadoteridol—Chest pain—Gemcitabine—kidney cancer	0.00174	0.00174	CcSEcCtD
Gadoteridol—Discomfort—Gemcitabine—kidney cancer	0.00172	0.00172	CcSEcCtD
Gadoteridol—Urticaria—Sorafenib—kidney cancer	0.00171	0.00171	CcSEcCtD
Gadoteridol—Erythema—Paclitaxel—kidney cancer	0.00171	0.00171	CcSEcCtD
Gadoteridol—Diarrhoea—Vinblastine—kidney cancer	0.00171	0.00171	CcSEcCtD
Gadoteridol—Body temperature increased—Sorafenib—kidney cancer	0.0017	0.0017	CcSEcCtD
Gadoteridol—Abdominal pain—Sorafenib—kidney cancer	0.0017	0.0017	CcSEcCtD
Gadoteridol—Diarrhoea—Everolimus—kidney cancer	0.0017	0.0017	CcSEcCtD
Gadoteridol—Hyperhidrosis—Vincristine—kidney cancer	0.0017	0.0017	CcSEcCtD
Gadoteridol—Pruritus—Erlotinib—kidney cancer	0.0017	0.0017	CcSEcCtD
Gadoteridol—Pain—Dactinomycin—kidney cancer	0.00168	0.00168	CcSEcCtD
Gadoteridol—Dysgeusia—Paclitaxel—kidney cancer	0.00167	0.00167	CcSEcCtD
Gadoteridol—Anaphylactic shock—Gemcitabine—kidney cancer	0.00167	0.00167	CcSEcCtD
Gadoteridol—Oedema—Gemcitabine—kidney cancer	0.00167	0.00167	CcSEcCtD
Gadoteridol—Dizziness—Vinblastine—kidney cancer	0.00165	0.00165	CcSEcCtD
Gadoteridol—Dizziness—Everolimus—kidney cancer	0.00164	0.00164	CcSEcCtD
Gadoteridol—Body temperature increased—Sunitinib—kidney cancer	0.00164	0.00164	CcSEcCtD
Gadoteridol—Abdominal pain—Sunitinib—kidney cancer	0.00164	0.00164	CcSEcCtD
Gadoteridol—Diarrhoea—Erlotinib—kidney cancer	0.00164	0.00164	CcSEcCtD
Gadoteridol—Hypotension—Vincristine—kidney cancer	0.00164	0.00164	CcSEcCtD
Gadoteridol—Bradycardia—Capecitabine—kidney cancer	0.00164	0.00164	CcSEcCtD
Gadoteridol—Feeling abnormal—Dactinomycin—kidney cancer	0.00162	0.00162	CcSEcCtD
Gadoteridol—Rhinitis—Capecitabine—kidney cancer	0.00161	0.00161	CcSEcCtD
Gadoteridol—Hyperhidrosis—Gemcitabine—kidney cancer	0.00161	0.00161	CcSEcCtD
Gadoteridol—Tremor—Paclitaxel—kidney cancer	0.0016	0.0016	CcSEcCtD
Gadoteridol—Hypersensitivity—Sorafenib—kidney cancer	0.00159	0.00159	CcSEcCtD
Gadoteridol—Vomiting—Vinblastine—kidney cancer	0.00159	0.00159	CcSEcCtD
Gadoteridol—Dizziness—Erlotinib—kidney cancer	0.00159	0.00159	CcSEcCtD
Gadoteridol—Ill-defined disorder—Paclitaxel—kidney cancer	0.00158	0.00158	CcSEcCtD
Gadoteridol—Vomiting—Everolimus—kidney cancer	0.00158	0.00158	CcSEcCtD
Gadoteridol—Paraesthesia—Vincristine—kidney cancer	0.00158	0.00158	CcSEcCtD
Gadoteridol—Rash—Everolimus—kidney cancer	0.00157	0.00157	CcSEcCtD
Gadoteridol—Dermatitis—Everolimus—kidney cancer	0.00156	0.00156	CcSEcCtD
Gadoteridol—Headache—Vinblastine—kidney cancer	0.00156	0.00156	CcSEcCtD
Gadoteridol—Headache—Everolimus—kidney cancer	0.00156	0.00156	CcSEcCtD
Gadoteridol—Hypotension—Gemcitabine—kidney cancer	0.00156	0.00156	CcSEcCtD
Gadoteridol—Abdominal pain—Dactinomycin—kidney cancer	0.00155	0.00155	CcSEcCtD
Gadoteridol—Body temperature increased—Dactinomycin—kidney cancer	0.00155	0.00155	CcSEcCtD
Gadoteridol—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.00155	0.00155	CcSEcCtD
Gadoteridol—Malaise—Paclitaxel—kidney cancer	0.00154	0.00154	CcSEcCtD
Gadoteridol—Syncope—Paclitaxel—kidney cancer	0.00153	0.00153	CcSEcCtD
Gadoteridol—Hypersensitivity—Sunitinib—kidney cancer	0.00153	0.00153	CcSEcCtD
Gadoteridol—Pruritus—Sorafenib—kidney cancer	0.00153	0.00153	CcSEcCtD
Gadoteridol—Vomiting—Erlotinib—kidney cancer	0.00152	0.00152	CcSEcCtD
Gadoteridol—Rash—Erlotinib—kidney cancer	0.00151	0.00151	CcSEcCtD
Gadoteridol—Dermatitis—Erlotinib—kidney cancer	0.00151	0.00151	CcSEcCtD
Gadoteridol—Headache—Erlotinib—kidney cancer	0.0015	0.0015	CcSEcCtD
Gadoteridol—Tinnitus—Capecitabine—kidney cancer	0.0015	0.0015	CcSEcCtD
Gadoteridol—Loss of consciousness—Paclitaxel—kidney cancer	0.0015	0.0015	CcSEcCtD
Gadoteridol—Pain—Vincristine—kidney cancer	0.0015	0.0015	CcSEcCtD
Gadoteridol—Paraesthesia—Gemcitabine—kidney cancer	0.0015	0.0015	CcSEcCtD
Gadoteridol—Flushing—Capecitabine—kidney cancer	0.00149	0.00149	CcSEcCtD
Gadoteridol—Cough—Paclitaxel—kidney cancer	0.00149	0.00149	CcSEcCtD
Gadoteridol—Dyspnoea—Gemcitabine—kidney cancer	0.00148	0.00148	CcSEcCtD
Gadoteridol—Nausea—Vinblastine—kidney cancer	0.00148	0.00148	CcSEcCtD
Gadoteridol—Convulsion—Paclitaxel—kidney cancer	0.00148	0.00148	CcSEcCtD
Gadoteridol—Nausea—Everolimus—kidney cancer	0.00148	0.00148	CcSEcCtD
Gadoteridol—Diarrhoea—Sorafenib—kidney cancer	0.00148	0.00148	CcSEcCtD
Gadoteridol—Hypertension—Paclitaxel—kidney cancer	0.00147	0.00147	CcSEcCtD
Gadoteridol—Pruritus—Sunitinib—kidney cancer	0.00147	0.00147	CcSEcCtD
Gadoteridol—Chest pain—Paclitaxel—kidney cancer	0.00145	0.00145	CcSEcCtD
Gadoteridol—Anxiety—Paclitaxel—kidney cancer	0.00145	0.00145	CcSEcCtD
Gadoteridol—Face oedema—Doxorubicin—kidney cancer	0.00145	0.00145	CcSEcCtD
Gadoteridol—Hypersensitivity—Dactinomycin—kidney cancer	0.00145	0.00145	CcSEcCtD
Gadoteridol—Discomfort—Paclitaxel—kidney cancer	0.00144	0.00144	CcSEcCtD
Gadoteridol—Cardiac arrest—Doxorubicin—kidney cancer	0.00143	0.00143	CcSEcCtD
Gadoteridol—Dizziness—Sorafenib—kidney cancer	0.00143	0.00143	CcSEcCtD
Gadoteridol—Pain—Gemcitabine—kidney cancer	0.00142	0.00142	CcSEcCtD
Gadoteridol—Nausea—Erlotinib—kidney cancer	0.00142	0.00142	CcSEcCtD
Gadoteridol—Dry mouth—Paclitaxel—kidney cancer	0.00142	0.00142	CcSEcCtD
Gadoteridol—Diarrhoea—Sunitinib—kidney cancer	0.00142	0.00142	CcSEcCtD
Gadoteridol—Erythema—Capecitabine—kidney cancer	0.0014	0.0014	CcSEcCtD
Gadoteridol—Anaphylactic shock—Paclitaxel—kidney cancer	0.00139	0.00139	CcSEcCtD
Gadoteridol—Oedema—Paclitaxel—kidney cancer	0.00139	0.00139	CcSEcCtD
Gadoteridol—Abdominal pain—Vincristine—kidney cancer	0.00139	0.00139	CcSEcCtD
Gadoteridol—Body temperature increased—Vincristine—kidney cancer	0.00139	0.00139	CcSEcCtD
Gadoteridol—Dysgeusia—Capecitabine—kidney cancer	0.00137	0.00137	CcSEcCtD
Gadoteridol—Dizziness—Sunitinib—kidney cancer	0.00137	0.00137	CcSEcCtD
Gadoteridol—Feeling abnormal—Gemcitabine—kidney cancer	0.00137	0.00137	CcSEcCtD
Gadoteridol—Shock—Paclitaxel—kidney cancer	0.00137	0.00137	CcSEcCtD
Gadoteridol—Vomiting—Sorafenib—kidney cancer	0.00137	0.00137	CcSEcCtD
Gadoteridol—Rash—Sorafenib—kidney cancer	0.00136	0.00136	CcSEcCtD
Gadoteridol—Dermatitis—Sorafenib—kidney cancer	0.00136	0.00136	CcSEcCtD
Gadoteridol—Headache—Sorafenib—kidney cancer	0.00135	0.00135	CcSEcCtD
Gadoteridol—Hyperhidrosis—Paclitaxel—kidney cancer	0.00135	0.00135	CcSEcCtD
Gadoteridol—Diarrhoea—Dactinomycin—kidney cancer	0.00134	0.00134	CcSEcCtD
Gadoteridol—Vomiting—Sunitinib—kidney cancer	0.00132	0.00132	CcSEcCtD
Gadoteridol—Body temperature increased—Gemcitabine—kidney cancer	0.00132	0.00132	CcSEcCtD
Gadoteridol—Tremor—Capecitabine—kidney cancer	0.00131	0.00131	CcSEcCtD
Gadoteridol—Rash—Sunitinib—kidney cancer	0.00131	0.00131	CcSEcCtD
Gadoteridol—Dermatitis—Sunitinib—kidney cancer	0.00131	0.00131	CcSEcCtD
Gadoteridol—Hypotension—Paclitaxel—kidney cancer	0.0013	0.0013	CcSEcCtD
Gadoteridol—Ill-defined disorder—Capecitabine—kidney cancer	0.0013	0.0013	CcSEcCtD
Gadoteridol—Headache—Sunitinib—kidney cancer	0.0013	0.0013	CcSEcCtD
Gadoteridol—Dysphagia—Doxorubicin—kidney cancer	0.0013	0.0013	CcSEcCtD
Gadoteridol—Hypersensitivity—Vincristine—kidney cancer	0.00129	0.00129	CcSEcCtD
Gadoteridol—Nausea—Sorafenib—kidney cancer	0.00128	0.00128	CcSEcCtD
Gadoteridol—Malaise—Capecitabine—kidney cancer	0.00126	0.00126	CcSEcCtD
Gadoteridol—Syncope—Capecitabine—kidney cancer	0.00126	0.00126	CcSEcCtD
Gadoteridol—Paraesthesia—Paclitaxel—kidney cancer	0.00125	0.00125	CcSEcCtD
Gadoteridol—Vomiting—Dactinomycin—kidney cancer	0.00125	0.00125	CcSEcCtD
Gadoteridol—Dyspnoea—Paclitaxel—kidney cancer	0.00124	0.00124	CcSEcCtD
Gadoteridol—Rash—Dactinomycin—kidney cancer	0.00124	0.00124	CcSEcCtD
Gadoteridol—Nausea—Sunitinib—kidney cancer	0.00123	0.00123	CcSEcCtD
Gadoteridol—Loss of consciousness—Capecitabine—kidney cancer	0.00123	0.00123	CcSEcCtD
Gadoteridol—Cough—Capecitabine—kidney cancer	0.00122	0.00122	CcSEcCtD
Gadoteridol—Hypertension—Capecitabine—kidney cancer	0.00121	0.00121	CcSEcCtD
Gadoteridol—Diarrhoea—Vincristine—kidney cancer	0.0012	0.0012	CcSEcCtD
Gadoteridol—Chest pain—Capecitabine—kidney cancer	0.00119	0.00119	CcSEcCtD
Gadoteridol—Pain—Paclitaxel—kidney cancer	0.00119	0.00119	CcSEcCtD
Gadoteridol—Anxiety—Capecitabine—kidney cancer	0.00119	0.00119	CcSEcCtD
Gadoteridol—Discomfort—Capecitabine—kidney cancer	0.00118	0.00118	CcSEcCtD
Gadoteridol—Pruritus—Gemcitabine—kidney cancer	0.00118	0.00118	CcSEcCtD
Gadoteridol—Dry mouth—Capecitabine—kidney cancer	0.00117	0.00117	CcSEcCtD
Gadoteridol—Nausea—Dactinomycin—kidney cancer	0.00117	0.00117	CcSEcCtD
Gadoteridol—Dizziness—Vincristine—kidney cancer	0.00116	0.00116	CcSEcCtD
Gadoteridol—Feeling abnormal—Paclitaxel—kidney cancer	0.00115	0.00115	CcSEcCtD
Gadoteridol—Oedema—Capecitabine—kidney cancer	0.00114	0.00114	CcSEcCtD
Gadoteridol—Diarrhoea—Gemcitabine—kidney cancer	0.00114	0.00114	CcSEcCtD
Gadoteridol—Shock—Capecitabine—kidney cancer	0.00113	0.00113	CcSEcCtD
Gadoteridol—Vomiting—Vincristine—kidney cancer	0.00112	0.00112	CcSEcCtD
Gadoteridol—Sweating—Doxorubicin—kidney cancer	0.00111	0.00111	CcSEcCtD
Gadoteridol—Urticaria—Paclitaxel—kidney cancer	0.00111	0.00111	CcSEcCtD
Gadoteridol—Rash—Vincristine—kidney cancer	0.00111	0.00111	CcSEcCtD
Gadoteridol—Hyperhidrosis—Capecitabine—kidney cancer	0.00111	0.00111	CcSEcCtD
Gadoteridol—Dermatitis—Vincristine—kidney cancer	0.00111	0.00111	CcSEcCtD
Gadoteridol—Abdominal pain—Paclitaxel—kidney cancer	0.0011	0.0011	CcSEcCtD
Gadoteridol—Body temperature increased—Paclitaxel—kidney cancer	0.0011	0.0011	CcSEcCtD
Gadoteridol—Headache—Vincristine—kidney cancer	0.0011	0.0011	CcSEcCtD
Gadoteridol—Hypotension—Capecitabine—kidney cancer	0.00107	0.00107	CcSEcCtD
Gadoteridol—Vomiting—Gemcitabine—kidney cancer	0.00106	0.00106	CcSEcCtD
Gadoteridol—Bradycardia—Doxorubicin—kidney cancer	0.00106	0.00106	CcSEcCtD
Gadoteridol—Rash—Gemcitabine—kidney cancer	0.00105	0.00105	CcSEcCtD
Gadoteridol—Dermatitis—Gemcitabine—kidney cancer	0.00105	0.00105	CcSEcCtD
Gadoteridol—Headache—Gemcitabine—kidney cancer	0.00104	0.00104	CcSEcCtD
Gadoteridol—Nausea—Vincristine—kidney cancer	0.00104	0.00104	CcSEcCtD
Gadoteridol—Rhinitis—Doxorubicin—kidney cancer	0.00104	0.00104	CcSEcCtD
Gadoteridol—Paraesthesia—Capecitabine—kidney cancer	0.00103	0.00103	CcSEcCtD
Gadoteridol—Hypersensitivity—Paclitaxel—kidney cancer	0.00103	0.00103	CcSEcCtD
Gadoteridol—Dyspnoea—Capecitabine—kidney cancer	0.00102	0.00102	CcSEcCtD
Gadoteridol—Nausea—Gemcitabine—kidney cancer	0.000989	0.000989	CcSEcCtD
Gadoteridol—Pruritus—Paclitaxel—kidney cancer	0.000986	0.000986	CcSEcCtD
Gadoteridol—Pain—Capecitabine—kidney cancer	0.000978	0.000978	CcSEcCtD
Gadoteridol—Tinnitus—Doxorubicin—kidney cancer	0.000968	0.000968	CcSEcCtD
Gadoteridol—Flushing—Doxorubicin—kidney cancer	0.000963	0.000963	CcSEcCtD
Gadoteridol—Diarrhoea—Paclitaxel—kidney cancer	0.000954	0.000954	CcSEcCtD
Gadoteridol—Feeling abnormal—Capecitabine—kidney cancer	0.000943	0.000943	CcSEcCtD
Gadoteridol—Dizziness—Paclitaxel—kidney cancer	0.000922	0.000922	CcSEcCtD
Gadoteridol—Urticaria—Capecitabine—kidney cancer	0.000909	0.000909	CcSEcCtD
Gadoteridol—Body temperature increased—Capecitabine—kidney cancer	0.000904	0.000904	CcSEcCtD
Gadoteridol—Abdominal pain—Capecitabine—kidney cancer	0.000904	0.000904	CcSEcCtD
Gadoteridol—Erythema—Doxorubicin—kidney cancer	0.000904	0.000904	CcSEcCtD
Gadoteridol—Vomiting—Paclitaxel—kidney cancer	0.000886	0.000886	CcSEcCtD
Gadoteridol—Dysgeusia—Doxorubicin—kidney cancer	0.000885	0.000885	CcSEcCtD
Gadoteridol—Rash—Paclitaxel—kidney cancer	0.000879	0.000879	CcSEcCtD
Gadoteridol—Dermatitis—Paclitaxel—kidney cancer	0.000878	0.000878	CcSEcCtD
Gadoteridol—Headache—Paclitaxel—kidney cancer	0.000873	0.000873	CcSEcCtD
Gadoteridol—Hypersensitivity—Capecitabine—kidney cancer	0.000843	0.000843	CcSEcCtD
Gadoteridol—Ill-defined disorder—Doxorubicin—kidney cancer	0.000838	0.000838	CcSEcCtD
Gadoteridol—Nausea—Paclitaxel—kidney cancer	0.000828	0.000828	CcSEcCtD
Gadoteridol—Malaise—Doxorubicin—kidney cancer	0.000815	0.000815	CcSEcCtD
Gadoteridol—Syncope—Doxorubicin—kidney cancer	0.00081	0.00081	CcSEcCtD
Gadoteridol—Pruritus—Capecitabine—kidney cancer	0.000809	0.000809	CcSEcCtD
Gadoteridol—Loss of consciousness—Doxorubicin—kidney cancer	0.000794	0.000794	CcSEcCtD
Gadoteridol—Cough—Doxorubicin—kidney cancer	0.000788	0.000788	CcSEcCtD
Gadoteridol—Convulsion—Doxorubicin—kidney cancer	0.000783	0.000783	CcSEcCtD
Gadoteridol—Diarrhoea—Capecitabine—kidney cancer	0.000783	0.000783	CcSEcCtD
Gadoteridol—Hypertension—Doxorubicin—kidney cancer	0.00078	0.00078	CcSEcCtD
Gadoteridol—Chest pain—Doxorubicin—kidney cancer	0.000769	0.000769	CcSEcCtD
Gadoteridol—Anxiety—Doxorubicin—kidney cancer	0.000767	0.000767	CcSEcCtD
Gadoteridol—Discomfort—Doxorubicin—kidney cancer	0.00076	0.00076	CcSEcCtD
Gadoteridol—Dizziness—Capecitabine—kidney cancer	0.000757	0.000757	CcSEcCtD
Gadoteridol—Dry mouth—Doxorubicin—kidney cancer	0.000752	0.000752	CcSEcCtD
Gadoteridol—Anaphylactic shock—Doxorubicin—kidney cancer	0.000737	0.000737	CcSEcCtD
Gadoteridol—Oedema—Doxorubicin—kidney cancer	0.000737	0.000737	CcSEcCtD
Gadoteridol—Vomiting—Capecitabine—kidney cancer	0.000727	0.000727	CcSEcCtD
Gadoteridol—Shock—Doxorubicin—kidney cancer	0.000726	0.000726	CcSEcCtD
Gadoteridol—Rash—Capecitabine—kidney cancer	0.000721	0.000721	CcSEcCtD
Gadoteridol—Dermatitis—Capecitabine—kidney cancer	0.000721	0.000721	CcSEcCtD
Gadoteridol—Headache—Capecitabine—kidney cancer	0.000717	0.000717	CcSEcCtD
Gadoteridol—Hyperhidrosis—Doxorubicin—kidney cancer	0.000713	0.000713	CcSEcCtD
Gadoteridol—Hypotension—Doxorubicin—kidney cancer	0.000689	0.000689	CcSEcCtD
Gadoteridol—Nausea—Capecitabine—kidney cancer	0.00068	0.00068	CcSEcCtD
Gadoteridol—Paraesthesia—Doxorubicin—kidney cancer	0.000662	0.000662	CcSEcCtD
Gadoteridol—Dyspnoea—Doxorubicin—kidney cancer	0.000657	0.000657	CcSEcCtD
Gadoteridol—Pain—Doxorubicin—kidney cancer	0.000631	0.000631	CcSEcCtD
Gadoteridol—Feeling abnormal—Doxorubicin—kidney cancer	0.000608	0.000608	CcSEcCtD
Gadoteridol—Urticaria—Doxorubicin—kidney cancer	0.000586	0.000586	CcSEcCtD
Gadoteridol—Abdominal pain—Doxorubicin—kidney cancer	0.000583	0.000583	CcSEcCtD
Gadoteridol—Body temperature increased—Doxorubicin—kidney cancer	0.000583	0.000583	CcSEcCtD
Gadoteridol—Hypersensitivity—Doxorubicin—kidney cancer	0.000543	0.000543	CcSEcCtD
Gadoteridol—Pruritus—Doxorubicin—kidney cancer	0.000522	0.000522	CcSEcCtD
Gadoteridol—Diarrhoea—Doxorubicin—kidney cancer	0.000505	0.000505	CcSEcCtD
Gadoteridol—Dizziness—Doxorubicin—kidney cancer	0.000488	0.000488	CcSEcCtD
Gadoteridol—Vomiting—Doxorubicin—kidney cancer	0.000469	0.000469	CcSEcCtD
Gadoteridol—Rash—Doxorubicin—kidney cancer	0.000465	0.000465	CcSEcCtD
Gadoteridol—Dermatitis—Doxorubicin—kidney cancer	0.000465	0.000465	CcSEcCtD
Gadoteridol—Headache—Doxorubicin—kidney cancer	0.000462	0.000462	CcSEcCtD
Gadoteridol—Nausea—Doxorubicin—kidney cancer	0.000438	0.000438	CcSEcCtD
